Immune privilege in corneal transplantation.
ACAID
Aqueous humor
Corneal transplantation
Costimulatory molecules
Immune checkpoints
Immune privilege
Lymph-angiogenesis
Neuro-immune crosstalk
Regulatory T cells
Journal
Progress in retinal and eye research
ISSN: 1873-1635
Titre abrégé: Prog Retin Eye Res
Pays: England
ID NLM: 9431859
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
31
01
2019
revised:
14
04
2019
accepted:
16
04
2019
pubmed:
25
4
2019
medline:
5
3
2020
entrez:
25
4
2019
Statut:
ppublish
Résumé
Corneal transplantation is the most successful solid organ transplantation performed in humans. The extraordinary success of orthotopic corneal allografts, in both humans and experimental animals, is related to the phenomenon of "immune privilege". Inflammation is self-regulated to preserve ocular functions because the eye has immune privilege. At present, three major mechanisms are considered to provide immune privilege in corneal transplantation: 1) anatomical, cellular, and molecular barriers in the cornea; 2) tolerance related to anterior chamber-associated immune deviation and regulatory T cells; and 3) an immunosuppressive intraocular microenvironment. This review describes the mechanisms of immune privilege that have been elucidated from animal models of ocular inflammation, especially those involving corneal transplantation, and its relevance for the clinic. An update on molecular, cellular, and neural interactions in local and systemic immune regulation is provided. Therapeutic strategies for restoring immune privilege are also discussed.
Identifiants
pubmed: 31014973
pii: S1350-9462(19)30001-1
doi: 10.1016/j.preteyeres.2019.04.002
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
100758Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.